Justin Blood

[Justin Blood @JustinBlood1]

@SABOURETCardio @GeoWizz_ Any thoughts on when France will approve? Or, if they will consider the new information for a stand alone label?

[Triglyceride Forum @TriglycerideF]

#Icosapentethyl improved #CVoutcomes in REDUCE-IT, but what are clinicians finding in everyday practice? Take a look at a real-world study reported at #ACC24 and summarised on Triglyceride Forum >> https://t.co/qNCOke9fya
#triglycerides #fishoils #heartattacks #MACE

[PACE-CME @PACEcme]

Sharing insights after study results with icosapent ethyl

Where do we stand after results of large clinical trials with icosapent ethyl and emerging data of additional studies? @gabrielsteg and @ProfKausikRay discuss the findings and share their insights

https://t.co/gnCTShJn9F

[Justin Blood @JustinBlood1]

@MarkBrady2014 @drpablocorral @DLBHATTMD @Drlipid Hi Mark,

May I have your email. Mine is [email protected].

I'm curious about a post on IHub.

[Justin Blood @JustinBlood1]

@DLBHATTMD @cpgale3 @gonzaeperez @ESC_Journals @SIAC_cardio @siacprevent @DrPontecarlosi @rigotordoc @cingolani_oscar @SeguraCardio @ValleAlfonso @ezeforte @sigal_alan @jpcostabel ☝️

[Justin Blood @JustinBlood1]

@soonergise @ercolevolpe1 @drpablocorral And, EPA is Vascepa/Vazkepa.

[Justin Blood @JustinBlood1]

@HeatherEHeying @arachnidpianist You believe something that is factually incorrect. Why spread factually incorrect information?

[Amarin @Amarincorp]

Today, Amarin congratulates its partner Edding Pharm on its first commercial sale of VASCEPA (icosapent ethyl) in Mainland China. This marks another important step in the effort to ensure access to this novel treatment for patients across that country.

[Justin Blood @JustinBlood1]

@MohammedAlo @shivadas29 @Jdp227 @drscottyk @AAgarwalaMD What prior studies are you referring to? Were those other studies using EPA?

[Justin Blood @JustinBlood1]

@johnkarony So, you're still not meeting g objectives communicated on the roadmap.

[Amarin @Amarincorp]

#BreakingNews: Today Amarin and Neopharm announced their exclusive commercialization agreement for VAZKEPA® (icosapent ethyl) in Israel. This agreement comes following April’s announcement from the Israeli Ministry of Health granting VAZKEPA regulatory approval in Israel.

[Justin Blood @JustinBlood1]

@safemoon You're bottling John's tears. Price is derived from the equilibrium of supply v. demand. High supply low demand = and additional $25.00 to market cap! Nice!

[Justin Blood @JustinBlood1]

@drpablocorral @society_eas @ATHjournal Vascepa/Vazkepa.

[Shibetoshi Nakamoto @BillyM2k]

insurance scamming squirrel

[Justin Blood @JustinBlood1]

@drpablocorral @GeoWizz_ But aren't all trials?

[SABOURETCardiologist @SABOURETCardio]

#EASCongress2023 #myEAS ePoster about eligibility to #EPA in a population of unselected #CAD patients with #T2D. One-third is eligible according to current indications #REDUCE-IT

[Amarin @Amarincorp]

This morning we announced details for our upcoming Q1 Earnings call. Watch the webcast live on May 3, at 8am ET. #Earnings $AMRN

[Justin Blood @JustinBlood1]

@SFMoonknight They also could have responded to https://t.co/ONSxPlbVx0 employees that identifed the vulnerability and patched it before it became an issue. IDK.

[Justin Blood @JustinBlood1]

@MarkBrady2014 @hawaii_imua @PeterAttiaMD Appreciate you, Mark!

[Justin Blood @JustinBlood1]

@MarkBrady2014 @drpablocorral Well said, Mark!